Health Condition 1: H431- Vitreous hemorrhage
Conditions
Interventions
Intervention1: Eye drops Homatropine 2%: Topical 2% homatropine eye
drops solution 3 times a day for 21 days
Control Intervention1: Head Elevation: Sleep with two standard size pillows so as
to kee
Sponsors
AIIMS Bathinda
Eligibility
Inclusion criteria
Inclusion criteria: Best corrected visual acuity (BCVA) HMCF to 6/12 and plan to conservatively manage VH.Fresh Vitreous Haemorrhage will be defined as Clinically diagnosed, first time spontaneous VH dense enough to obscure some part of the retina, with duration of less than 2 weeks of onset.
Exclusion criteria
Exclusion criteria: Recurrent VH, VH with ultrasonic evidence of retinal tears or rhegmatogenous retinal detachment or tumour, previous treatment with intravitreal drugs, trauma, intraocular surgery within one month,advanced cataract precluding examination of posterior segment, neovascularisation of the iris (NVA)or angle (NVA), glaucoma or high IOP,systemic diseases limiting patientâ??s ability to be complaint with positioning, h/o allergy to homatropine E/ds
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objective is change in BCVA at end of study period.Timepoint: Participants in all groups will be examined in a similar fashion on Day 1,3,7,15 and 21 days for a period of 3 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondarily resolution of VH will also be assessed using VH grading scalesTimepoint: Participants in all groups will be examined in a similar fashion on Day 1,3,7,15 and 21 days for a period of 3 weeks | — |
Countries
India
Contacts
Public ContactDr Sanjeev Kumar
AIIMS, Bathinda
Outcome results
None listed